In addition, tumor cells may enhance resistance to DNA-damaging drugs by up-regulating the expression of DNA repair enzymes (such as Topoisomerase Iα), or by activating alternative survival signaling pathways (such as the PI3K/AKT/mTOR pathway) to bypass drug targets 110. Here, AKT1 is linked to neoplasm.